MedPath
FDA Approval

Lorazepam

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Contract Pharmacy Services-PA
DUNS: 945429777
Effective Date
March 4, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Lorazepam(2 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Coupler Enterprises Inc.

Contract Pharmacy Services-PA

945429777

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lorazepam

Product Details

NDC Product Code
67046-888
Application Number
ANDA203572
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 4, 2020
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQUClass: IACT
LorazepamActive
Code: O26FZP769LClass: ACTIBQuantity: 2 mg in 1 1

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

BOXED WARNING SECTION

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS


© Copyright 2025. All Rights Reserved by MedPath